ENGN enGene: Accounting Capitalization
Price evolution data for enGene Holdings Inc. (ENGN) illustrates the business dynamics of a company developing safe, non-viral DNA delivery for mucosal therapies and the treatment of bladder oncology. The current metric stands at 0.23. enGene Holdings Inc. (ENGN) relies on external contractors (CROs and CMOs) for conducting research and vector production. Vendor dependency risks are mitigated by strict global control over plasmid production lines.
%20-%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ENGN_-_enGene-Holdings-Inc._-_Company-Book-Value "ENGN enGene Holdings Inc Net Asset Value (02/21/2024 - 11/01/2026) | 👁️GURU.Markets👁️")
ENGN (enGene): analytical breakdowns and indicator data
- stock value and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital enGene Holdings Inc.|ENGN - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital enGene Holdings Inc|ENGN - Company Debts|Debt to Book Value enGene Holdings Inc|ENGN - Company Long-Term Debts|Company Short-Term Debts enGene|Intermediate Coverage Ratio engene.com
- earnings and market ratios statistics:
Initial company analysis:enGene Holdings Inc.
enGene Holdings Inc. is developing an innovative, patent-protected virus-free gene therapy platform. The company's asset dynamics directly determine the calculated net asset value minus liabilities. This metric measures the intrinsic value of the business, serving as a conservative buffer against market volatility. It is critical for investors to weigh this foundation against FDA costs. Analyzing the company's book capitalization allows for an assessment of the actual capital protection.
Competitor analysis for enGene Holdings Inc.
Book Value of Business argenx BVBA (ARGX)|BioNTech SE (BNTX) - Company Book Value|Accounting Capitalization ABVX|Company Book Value ADMA Biologics, Inc.|Protagonist Therapeutics, Inc. - Net Asset Value|Book Capitalization IMVT|KNSA (Kiniksa Corp) - Accounting Value of Company|Book Capitalization GRFS (Grifols, S.A.)|Book Capitalization adaptivebiotech.com ADPT|CLDX - Company Book Value|Accounting Value of Company AUPH (Aurinia Pharmaceuticals Inc)|BioCryst Pharmaceuticals Inc (BCRX) - Company Book Value|Company Net Assets Vera Corp|DNTH (Dianthus Therapeutics) - Book Capitalization|Book Capitalization pharvaris.com|Company Net Assets ABCL (AbCellera Bio)|TRML (Tourmaline Bio Inc) - Accounting Value of Company|Book Capitalization PGEN (Intrexon)|Book Valuation of Business Pharming Corp (PHAR)|NKTR - Company Book Value|upstreambio.com (UPB) - Company Net Assets|Zenas Biopharma (ZBIO) - Company Book Value|Company Net Assets Immunome Inc|Company Net Assets GOSS|Book Capitalization KalVista Corp|Company Book Value Septerna Inc (SEPN)|pieris.com - Accounting Capitalization|Book Capitalization SVRA (Savara)|Rigel Pharma (RIGL) - Total Stockholders' Equity|AnaptysBio Corp - Book Capitalization|Total Stockholders' Equity Astria Corp|RAPT Therapeutics, Inc. (RAPT) - Company Book Value|Accounting Capitalization JBIO|ACRS (Aclaris Therapeutics, Inc.) - Book Capitalization|KYTX - Book Value of Business|Book Capitalization TLSA|CABA - Total Stockholders' Equity|Company Book Value Ventyx Biosciences VTYX|THTX: Accounting Capitalization|Avalo Therapeutics - Book Capitalization|Total Stockholders' Equity Eledon Pharmaceuticals Inc.|AGEN (Agenus Inc) - Company Net Assets|Climb Bio, Inc - Accounting Value of Company|ZURA (Zura Bio Limited) - Book Capitalization|ATYR: Accounting Value of Company|Company Book Value Adagene (ADAG)|IMA - Total Stockholders' Equity|Company Book Value Shattuck Labs STTK|Equillium Inc - Company Book Value|Connect Pharma - Book Capitalization|IMUX (Immunic, Inc.) - Accounting Capitalization|ATRA: Book Capitalization|IFRX - Book Valuation of Business|Company Book Value X4 Pharma|Accounting Capitalization ACET (Adicet)|Book Capitalization CELU|inmunebio.com (INMB) - Book Value of Business|Company Book Value Barinthus Biotherapeutics plc BRNS|Book Valuation of Business Kezar Life Sciences Inc. (KZR)|SABS: Company Net Assets|Accounting Value of Company AKTX (Akari Therapeutics, Plc)|ENLV: Book Capitalization|QTTB - Book Valuation of Business|Company Book Value GeoVax|Accounting Capitalization EDSA (Edesa Biotech Inc)|Book Capitalization IBIO|Company Net Assets carismatx.com CARM|XTL Biopharmaceuticals - Company Net Assets|Book Valuation of Business Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics Inc - Book Capitalization|Total Stockholders' Equity Aptevo Therapeutics|AIM ImmunoTech (AIM) - Company Book Value|Accounting Capitalization ADTX|GRI (GRI Bio, Inc.) - Book Capitalization|XRTX - Book Value of Business|Company Book Value Vyome Holdings (HIND)|Revelation Biosciences Inc - Accounting Capitalization|Company Book Value Indaptus INDP|SCNI (BiondVax Pharmaceuticals) - Net Asset Value|CalciMedica Corp - Book Capitalization|Accounting Value of Company AFMD (Affimed)|ALLK: Book Capitalization|HOOKIPA Pharma (HOOK) - Book Capitalization|Company Book Value IGM Biosciences Inc.|ITOS: Accounting Value of Company|Company Book Value Ocean Biomedical, Inc. (OCEA)|Company Net Assets tcbiopharm.com TCBP|Book Capitalization THRD (Third Harmonic Bio, Inc.)